China Shineway Pharmaceutical Group Ltd. is an investment holding company, which engages in the research and development, manufacturing, and trading of Chinese pharmaceutical products. The company is headquartered in Shijiazhuang, Hebei. The company went IPO on 2004-12-02. The Company’s product dosage forms include injections, soft capsules, granules, traditional Chinese medicine (TCM) granules, oral products and other dosage forms. The Company’s products include Qing Kai Ling Injection, Shen Mai Injection, Wu Fu Xin Nao Qing Soft Capsule, Qing Kai Ling Soft Capsule, Huamoyan Granule, Compound Licorice Tablet and other products, applied to influenza, cardio-cerebrovascular, respiratory system and other disease fields. The firm operates its business in mainland China and Hong Kong markets.
Follow-Up Questions
What is China Shineway Pharmaceutical Group Ltd (CSWYY)'s P/E Ratio?
The P/E ratio of China Shineway Pharmaceutical Group Ltd is N/A
What is the price performance of CSWYY stock?
The current price of CSWYY is 0, it has decreased 0% in the last trading day.
What are the primary business themes or industries for China Shineway Pharmaceutical Group Ltd?
China Shineway Pharmaceutical Group Ltd belongs to Pharmaceuticals industry and the sector is Health Care
What is China Shineway Pharmaceutical Group Ltd market cap?
China Shineway Pharmaceutical Group Ltd's current market cap is $0
Is China Shineway Pharmaceutical Group Ltd a buy, sell, or hold?
According to wall street analysts, 7 analysts have made analyst ratings for China Shineway Pharmaceutical Group Ltd, including 3 strong buy, 3 buy, 1 hold, 0 sell, and 3 strong sell
